Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDRA Life Sciences Inc NDRA

Healthcare Medical Devices
ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into... see more

Recent & Breaking News (NDAQ:NDRA)

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

Business Wire 2 days ago

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

Business Wire 8 days ago

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

Business Wire October 22, 2024

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

Business Wire August 28, 2024

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Business Wire August 22, 2024

ENDRA Life Sciences Announces Reverse Stock Split

Business Wire August 16, 2024

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

Business Wire August 13, 2024

ENDRA Life Sciences Announces Leadership Changes

Business Wire August 13, 2024

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

Business Wire August 7, 2024

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

Business Wire June 4, 2024

ENDRA Provides Update Following In-person Meeting with FDA

Business Wire May 20, 2024

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

Business Wire May 14, 2024

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

Business Wire May 7, 2024

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

Business Wire May 2, 2024

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Business Wire March 28, 2024

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

Business Wire March 21, 2024

ENDRA Life Sciences Installs First TAEUS System in the UK

Business Wire February 27, 2024

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

Business Wire February 21, 2024

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

Business Wire February 14, 2024

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

Business Wire November 29, 2023